Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 5/4/09 AVI BioPharma Announces First Quarter 2009 Financial Results Conference Call 4/28/09 AVI BioPharma Receives Key Patents for Drug Candidate AVI-6002 Targeting Ebola Zaire Virus Protein VP35 3/31/09 AVI BioPharma Appoints Drs. Christopher S. Henney and M. Kathleen Behrens to Its Board of Directors 3/10/09 AVI BioPharma Announces Fourth Quarter and Year End 2008 Financial Results 3/4/09 AVI BioPharma Announces Fourth Quarter and Year End 2008 Financial Results Conference Call 2/19/09 AVI BioPharma Announces Treatment of First Patient in Systemic Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy 2/12/09 AVI BioPharma, Inc. Appoints Chief Medical Officer 1/30/09 AVI BioPharma, Inc. to Raise $16.5 Million in Registered Direct Offering 1/20/09 AVI BioPharma Announces Conference Call Wednesday, Jan. 21, 2009 to Provide Update on Duchenne Muscular Dystrophy Program 1/20/09 AVI BioPharma Announces Successful Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy by Exon Skipping Pagination First page « first Previous page ‹ previous … Page 65 Page 66 Page 67 Page 68 Current page 69 Page 70 Page 71 Page 72 Page 73 … Next page next › Last page last » Displaying 681 - 690 of 813 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 5/4/09 AVI BioPharma Announces First Quarter 2009 Financial Results Conference Call 4/28/09 AVI BioPharma Receives Key Patents for Drug Candidate AVI-6002 Targeting Ebola Zaire Virus Protein VP35 3/31/09 AVI BioPharma Appoints Drs. Christopher S. Henney and M. Kathleen Behrens to Its Board of Directors 3/10/09 AVI BioPharma Announces Fourth Quarter and Year End 2008 Financial Results 3/4/09 AVI BioPharma Announces Fourth Quarter and Year End 2008 Financial Results Conference Call 2/19/09 AVI BioPharma Announces Treatment of First Patient in Systemic Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy 2/12/09 AVI BioPharma, Inc. Appoints Chief Medical Officer 1/30/09 AVI BioPharma, Inc. to Raise $16.5 Million in Registered Direct Offering 1/20/09 AVI BioPharma Announces Conference Call Wednesday, Jan. 21, 2009 to Provide Update on Duchenne Muscular Dystrophy Program 1/20/09 AVI BioPharma Announces Successful Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy by Exon Skipping Pagination First page « first Previous page ‹ previous … Page 65 Page 66 Page 67 Page 68 Current page 69 Page 70 Page 71 Page 72 Page 73 … Next page next › Last page last » Displaying 681 - 690 of 813